Product NDC: | 63304-436 |
Proprietary Name: | FELODIPINEEXTENDED-RELEASE TABLETS |
Non Proprietary Name: | felodipine |
Active Ingredient(s): | 5 mg/1 & nbsp; felodipine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-436 |
Labeler Name: | Ranbaxy Pharmaceuticals Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019834 |
Marketing Category: | NDA |
Start Marketing Date: | 20080910 |
Package NDC: | 63304-436-01 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-436-01) |
NDC Code | 63304-436-01 |
Proprietary Name | FELODIPINEEXTENDED-RELEASE TABLETS |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-436-01) |
Product NDC | 63304-436 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | felodipine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20080910 |
Marketing Category Name | NDA |
Labeler Name | Ranbaxy Pharmaceuticals Inc |
Substance Name | FELODIPINE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |